【レポートの概要(一部)】
1. Report Overview
1.1 Overview of the World Market for Colorectal Cancer Drugs
1.2 Why You Should Read This Report
1.3 How This Study Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Colorectal Cancer and Treatments
2.1 Pathophysiology of Colorectal Cancer
2.2 Epidemiology of Colorectal Cancer
2.2.1 Incidence – Increases with Age
2.2.2 Mortality – Fourth-Leading Cause of Cancer Death
2.2.3 Survival – Depends on Stage of Cancer
2.3 Diagnosis – Benefits and Limitations
2.4 Treatment and Staging
2.4.1 Treatment Options
2.4.2 Staging in Colorectal Cancers
2.4.3 Treatment Depending on Stages
3. The World Colorectal Cancer Drugs Market, 2015-2025
3.1 Global Colorectal Cancer Drugs Market Forecast 2015-2025
3.2 Geographical Colorectal Cancer Drugs Market Forecasts 2015-2025
3.2.1 The US Colorectal Cancer Drugs Market, 2015-2025
3.2.1.1 The US Colorectal Cancer Drugs Market Forecast – Stagnant Growth
3.2.2 The Japanese Colorectal Cancer Drugs Market, 2015-2025
3.2.2.1 The Japanese Colorectal Cancer Drugs Market Forecast – High Price of Biosimilars Will Drive the Market
3.2.3 The EU Colorectal Cancer Drugs Market, 2015-2025
3.2.3.1 The EU Colorectal Cancer Drugs Market Forecast – Tough Regulatory Environment Will Slow Market Growth
3.2.4 The APAC Countries Colorectal Cancer Drugs Market, 2015-2025
3.2.4.1 The APAC Colorectal Cancer Drugs Market Forecast – Market Will Be Stimulated by Rising Incidence of Cancer Owing to Changes of Lifestyle
3.2.5 Rest of the World Colorectal Cancer Drugs Market, 2015-2025
3.2.5.1 Rest of the World Colorectal Cancer Drugs Market Forecast
4. The Top Colorectal Cancer Drugs: Revenue Forecasts, 2015-2025
4.1 Avastin (Roche)
4.1.1 Avastin Revenue Forecast – Leader of the Pack
4.1.2 Roche
4.2 Erbitux (BMS/Merck KGaA)
4.2.1 Erbitux Revenue Forecast – Will its Revenue be Eroded by Biosimilars?
4.2.2 BMS
4.2.3 Merck KGaA
4.3 Xeloda (Roche)
4.3.1 Xeloda Revenue Forecast – Declining Sharply
4.4 Vectibix (Amgen)
4.4.1 Vectibix Revenue Forecast – Sales Will Grow During the First Half of the Forecast Period
4.4.2 Amgen
4.5 Eloxatin (Sanofi)
4.5.1 Eloxatin Revenue Forecast – Declining Slowly
4.5.2 Sanofi
4.6 Zaltrap (Sanofi/Co-developed with Regeneron)
4.6.1 Zaltrap Revenue Forecast – Sales Expected to Grow Significantly Until 2020
4.7 Stivarga (Bayer)
4.7.1 Stivarga Revenue Forecast – Positive Growth Trend
4.7.2 Bayer
4.8 TS-1 (Taiho Pharmaceuticals)
4.8.1 TS-1 Revenue Forecast
4.8.2 Taiho Pharmaceuticals
4.9 Cyramza (Eli Lilly)
4.9.1 Cyramza Revenue Forecast – Additional Approval for mCRC Will Drive Sales
4.9.2 Eli Lilly
5. Emerging Therapies
5.1 Lonsurf (Taiho Pharmaceuticals) – Approved in Japan
5.2 Sym-004 (Symphogen) – Promising Results in Early Human Clinical Trials
5.3 IMMU-130/Labetuzumab-SN-38 (Immunomedics) – ADC with High Anti-Tumour Activity
6. R&D Pipelines for Colorectal Cancer Treatment
6.1 CPX-1 (Celator Pharmaceuticals) – Combination of Irinotecan HCl and Floxuridine
6.2 CT-011/Pidilizumab (CureTech) – Binds to PD-1
6.3 Dabrafenib/Tafinlar (GSK) – Inhibitor of B-Raf
6.4 E7820 (Eisai) – Inhibits Integrin Alpha 2
6.5 Entinostat (Syndax Pharmaceuticals) – Exhibits a Wide Range of Anti-Tumour Activity
6.6 Ganetespib (Synta Pharmaceuticals) – Inhibits Hsp90
6.7 LGX818/Encorafenib (Novartis) – Investigated in Several Trials
6.8 ABT-869/Linifanib (Abbott Laboratories) – Inhibits VEGF and PDGF Receptors
6.9 MORAb-004/Ontuxizumab (Morphotek, Inc.) – Targets Endosialin
6.10 Onartuzumab (Genentech) – Targets the Protein MET
6.11 JX-594 (SillaJen) – Oncolytic Virus
6.12 PF-05212384 (Pfizer) – PI3K/mTOR Inhibitor
6.13 Simtuzumab (Gilead) – Highly Selective for LOXL2
6.14 Talaporfin Sodium (Aptocine, Light Sciences Oncology) – Water-Soluble Drug
6.15 Tivantinib (ARQ 197; ArQule, Daiichi Sankyo) – An Option for EGFR-resistant MET-High mCRC Patients
6.16 Tivozanib (Astellas Pharma/Aveo Pharmaceuticals) – Inhibits VEGF Receptors
6.17 Trametinib (Mekinist, GlaxoSmithKline) – Blocks MEK1 and MEK2
6.18 Veliparib (ABT-888, AbbVie) – An Oral PARP
6.19 RG7221/ RO5520985/Vanucizumab (Roche) – Binds Ang2 and VEGF-A
6.20BKM-120/Buparlisib (Novartis) – Reduces Cellular Levels of Phosphorylated AKT
6.21 BYL-719/Alpelisib (Novartis)
7. Qualitative Analysis of the Colorectal-Cancer Drugs Market 2015-2025
7.1 SWOT Analysis of the Colorectal Cancer Drugs Market
7.1.1 Strengths
7.1.1.1 Rising Incidence of Cancer – Ageing Population
7.1.1.2 Multiple Treatment Options Are Usually Needed
7.1.2 Weaknesses
7.1.2.1 The Challenges of Drug Development
7.1.2.2 The Complex Nature of Cancer
7.1.3 Opportunities in the Cancer Drugs Market
7.1.3.1 The Advancement of Research
7.1.3.2 A Shift Towards Personalisation
7.1.4 Threats Facing the Cancer Drugs Market
7.1.4.1 The Threat of Regulation
7.2.1 Social Factors: The Cost of Living Longer
7.2.2 Technological Developments: Making the Market Move Forward
7.2.3 Economic Pressure: Treatment’s Hefty Price Tag
7.2.4 Political Issues: Governmental Involvement in Treatment
8. Research Interviews from Our Survey – 2015
8.1 Dr. Philip M. Arlen, President and CEO, Precision Biologics, Inc., US
8.1.1 Less Than 1% of Colonoscopies Screening Reveal Cancer
8.1.2 Market Driver – New Drugs with Novel MoA and Favourable Safety Profile
8.1.3 Ensituximab – Developed From a Tumour-Derived Cancer Vaccine
8.1.4 60% of Patients with Colorectal and Pancreatic Cancer Express the Ensituximab Target
8.2 Dr. John Beadle, CEO of PsiOxus Therapeutics, UK
8.2.1 Significant Unmet Need – Effective Treatments for MSI Normal and MSI Low Patients
8.2.2 Checkpoint Inhibitors – Work Well in MSI High Patients
8.2.3 Enadenotucirev Remains Stable in Human Blood
8.2.4 Enadenotucirev – Positioning in the Colorectal Cancer Market?
9. Conclusions of the Study
9.1 Patent Expiries and the Impact of Biosimilars
9.2 The US – Still the Largest National Market
9.3 APAC – Will Show the Fastest Growth
9.4 Colorectal Cancer Drugs R&D Pipeline – Crowded, but How Many Promising Drugs?
9.5 Concluding Remarks
【レポート販売概要】
■ タイトル:大腸癌治療薬の世界市場:治療、研究開発、市場予測■ 英文:Colorectal Cancer Drugs Industry and Market: Therapies, R&D and Forecasts 2015-2025
■ 発行日:2015年11月
■ 調査会社:visiongain
■ 商品コード:VGAIN5112513
■ 調査対象地域:グローバル
- 石油・ガス市場の契約動向:Iraq Refinery Award Boosts DownstreamMonthly Oil & Gas Industry Contracts Review: Iraq Refinery Award Boosts Downstream Summary GlobalData's “Monthly Oil & Gas Industry Contracts Review: Iraq Refinery Award Boosts Downstream”. The report is an essential source of data on the contracts and open tenders in the oil and gas industry. The report portrays detailed comparative data on the number of contracts and their value in the month, su …
- 世界の特殊食品成分市場動向(~2018)The specialty food ingredients market is experiencing new traction due to rise in the demand for healthier & tasty food and changing lifestyles of the consumers. This report estimates the market value of specialty ingredients by types and applications. In terms of geography, the report is segmented into Asia-Pacific, Europe, North America, and Rest of the World (ROW). The specialty food ingredient …
- セルフタンニング製品の世界市場2019-2023127 pages, November 2018 About this market The advent of natural and organic ingredients in self-tan products is expected to help the self-tan products grow. The demand for incorporating natural and organic ingredients in self-tan products is increasing, which are safe, have no harmful side effects, and be of higher quality than most synthetic products. Technavio’s analysts have predicted that the …
- 世界のスープ市場:ニュース、イベント動向(2014年3月)Synopsis The report provides a review of the latest news and key events in the global soups market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global soups market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global soups mar …
- 世界のセルロースアセテート-A市場2015The Global Cellulose Acetate - A Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Cellulose Acetate - A industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Cellulose Acetate - A market analysis is provided for the international markets including deve …
- てんかん(癲癇):世界医薬品市場予測及び市場分析PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both drugs have experienced signifi …
- スマート鉄道ソリューションの世界市場:旅客情報/貨物情報システム、セキュリティ/モニタリングシステム、鉄道通信/ネットワークシステム、スマート・チケッティング、鉄道分析MarketsandMarkets forecasts the smart railways market size to grow from USD 5.34 Billion in 2015 to USD 13.77 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 20.8% from 2015 to 2020. Railways are considered as an important mode of transportation for the economic and demographic development of the growing regions. It is one of the preferred modes of transportation for both passengers an …
- 世界の食品安定剤(食品添加物)市場動向及び予測(~2018)The food stabilizers (blend/system) are largely used in dairy, confectionery, bakery, and convenience food applications. The application of the blends in the food products is driven by the increasing consumption of convenience food. The increasing disposable income of consumers has led to the rise in the consumption of convenience food. The report provides detailed analysis of the stabilizer blend …
- 業務用スキンケア製品の世界市場2015-2019About professional skin care The global professional skin care market includes a variety of products that protect the skin against aging, dehydration, pigmentation, sunlight, and cellulite buildup. These products are specially designed for individual skin types. Professional skin care products are generally sold through spas and salons, medical institutions, and retail stores. The global professio …
- レーザー加工の世界市場分析:製品別(ガス、ソリッドステート、ファイバー)、プロセス別(材料加工、マーキング、マイクロ加工)、用途別(自動車、航空宇宙、医療)、セグメント予測、2014-2025The global laser processing market is expected to reach USD 23 billion by 2025, according to a new report by Grand View Research, Inc. The rising utilization of expensive laser-drilling technique for oil & gas exploration purposes is projected to substitute the traditional techniques. Decreasing drilling costs are anticipated to increase the feasibility of uneconomic oil deposits; thus, positively …
- クラウド環境上のコンピューティング、コンテンツ、アプリケーション及びコマース:通信事業者への脅威と機会(Computing, Content, Applications and Commerce in the Cloud: Legacy Network Operator Threats and Opportunities)Migration to the cloud will affect more than just IT outsourcing of datacenters. Cloud represents opportunities and threats to existing network operators as applications, content, commerce, and computing migrate to the cloud. Game changing technologies including 4G, IP Multimedia Subsystem, and cloud computing will transform wireless communications. This transformation will be a boon for some who …
- 舞踏病(Chorea):グローバル臨床試験レビュー(2014年上半期)Chorea Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chorea Global Clinical Trials Review, H1, 2014" provides data on the Chorea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chorea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- 包装ミューズリー製品の世界市場2018-2022About Packaged Muesli Products Muesli is a breakfast and brunch dish based on raw rolled oats and other ingredients like grains, fresh or dried fruits, seeds and nuts, that may be mixed with cow's milk, soy milk, almond milk, other plant milks, yogurt or fruit juices. Technavio’s analysts forecast the global packaged muesli products market to grow at a CAGR of 4.63% during the period 2018-2022. Co …
- 薬剤溶出ステントのグローバル製品パイプライン動向2015Drug Eluting Stents (DES) - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Drug Eluting Stents (DES) - Pipeline Review, 2015" provides an overview of Drug Eluting Stents currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major p …
- ロボット塗装ブースの世界市場2017-2021:塗装ブース、塗装ロボットAbout Robotic Paint Booth Almost every machine, ranging from a small component to an aircraft, requires a coat of paint over the metallic surface to protect it from corrosion. It is this need that makes manufacturers to adopt automated painting technologies in their facilities to ensure health safety of workers, improve throughput, and enhance process efficiency. Automated systems like paint robot …